🐢
|
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
12 auth.
A. Oosterom,
I. Judson,
J. Verweij,
S. Stroobants,
E. D. Paola,
S. Dimitrijević,
...
M. Martens,
A. Webb,
R. Sciot,
M. Glabbeke,
S. Silberman,
O. S. Nielsen
|
10 |
2001 |
10 🐢
|
🐜
|
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
59 auth.
J. Blay,
S. Bonvalot,
P. Casali,
Haesun Choi,
M. Debiec-Richter,
A. Tos,
J. Emile,
A. Gronchi,
P. Hogendoorn,
H. Joensuu,
A. Cesne,
Joan Mac Clure,
J. Maurel,
Ninna Nupponen,
I. Ray-Coquard,
...
P. Reichardt,
R. Sciot,
S. Stroobants,
M. Glabbeke,
A. Oosterom,
G. Demetri,
Ianis Boukovinas,
P. Meeus,
J. Janinis,
Rosella Bertulli,
M. Colecchia,
A. Messina,
E. Tamborini,
Seiichi Hirota,
T. Nishida,
J. Martin,
A. Poveda,
R. Ramos,
L. Guillou,
S. Leyvraz,
M. Leahy,
C. Corless,
R. DeMatteo,
J. Zalcberg,
Dolores Knufer,
Aage Schultz,
I. Judson,
B. Fervers,
B. Bui,
F. Coevorden,
R. S. Benjamin,
R. Maki,
J. Verweij,
O. S. Nielsen,
M. Heinrich,
B. V. Geel,
L. Baker,
M. Mehren,
T. Alvegård,
J. Coindre,
K. Antman,
P. Hohenberger,
K. Sundby-Hall,
P. Rutkowski
|
9 |
2005 |
9 🐜
|
🐢
|
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
15 auth.
A. Cesne,
J. Blay,
I. Judson,
A. Oosterom,
J. Verweij,
J. Radford,
P. Lorigan,
S. Rodenhuis,
I. Ray-Coquard,
S. Bonvalot,
...
F. Collin,
J. Jimeno,
E. D. Paola,
M. Glabbeke,
O. S. Nielsen
|
8 |
2005 |
8 🐢
|
🐢
|
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas.
M. Glabbeke,
J. Verweij,
I. Judson,
O. S. Nielsen
|
8 |
2002 |
8 🐢
|
🐜
|
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
11 auth.
A. Oosterom,
H. T. Mouridsen,
O. S. Nielsen,
P. Dombernowsky,
Krzysztof Krzemieniecki,
I. Judson,
...
L. Svancárová,
David Spooner,
Cédric Hermans,
M. Glabbeke,
J. Verweij
|
7 |
2002 |
7 🐜
|
🐜
|
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.
12 auth.
Lars Bastholt,
Mads Dalmark,
S. Gjedde,
Per Pfeiffer,
Dorte Pedersen,
Erik Sandberg,
...
M. Kjaer,
H. T. Mouridsen,
Carsten Rose,
O. S. Nielsen,
Preben Jakobsen,
Søren M. Bentzen
|
7 |
1996 |
7 🐜
|
🦁
|
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
14 auth.
O. S. Nielsen,
I. Judson,
Q. V. Hoesel,
A. Cesne,
H. Keizer,
J. Blay,
A. Oosterom,
J. Radford,
L. Svancárová,
K. Krzemienlecki,
...
C. Hermans,
M. Glabbeke,
J. Oosterhuis,
J. Verweij
|
7 |
2000 |
7 🦁
|
🦁
|
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
11 auth.
O. S. Nielsen,
P. Dombernowsky,
H. T. Mouridsen,
Derek Crowther,
Jaap Verweij,
J. Buesa,
...
W. Steward,
Søren Daugaard,
M. Glabbeke,
Anne Kirkpatrick,
T. Tursz
|
6 |
1998 |
6 🦁
|
🐜
|
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
11 auth.
P. Woll,
I. Judson,
Siow Ming Lee,
S. Rodenhuis,
O. S. Nielsen,
J. Buesa,
...
P. Lorigan,
Serge Leyvraz,
Cédric Hermans,
M. Glabbeke,
J. Verweij
|
6 |
1999 |
6 🐜
|
🐜
|
Imaging of chondrosarcoma with histopathological and prognostic correlation
7 auth.
A. Jurik,
O. M. Jensen,
J. Keller,
O. S. Nielsen,
E. Lundorf,
S. Daugaard,
...
O. Sneppen
|
2 |
1995 |
2 🐜
|
🐬
|
Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group
S. Gwyther,
O. S. Nielsen,
I. Judson,
M. V. Van Glabbeke,
J. Verweij
|
2 |
2000 |
2 🐬
|